ecrin-mdr-crcClinical2001Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2006602United States5Recurrent rectal cancerRecurrent colon cancerStage IV rectal cancerIrinotecanStage III rectal cancerCapecitabineStage IV colon cancerAdenocarcinoma of the colonAdenocarcinoma of the rectumStage III colon cancerECRIN MDRCompletedfalseCapecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal CancerPURPOSE: Phase II trial to study the effectiveness of combining capecitabine and irinotecan in treating patients who have locally advanced, recurrent, or metastatic colorectal cancer.2001-05-152006602NCT00022698